An Evaluation Of Checkpoint Therapeutics Inc (NASDAQ: CKPT) Prospects

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.

Stocks Info

CKPT belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Checkpoint Therapeutics Inc is $198.29M. A total of 0.88 million shares were traded on the day, compared to an average of 1.42M shares.

In the most recent transaction, Oliviero James F III sold 602,167 shares of CKPT for 3.87 per share on Dec 18 ’24. After the transaction, the CEO, President and Director now owns 3,414,813 company shares. In a previous transaction on Dec 19 ’24, Oliviero James F III sold 220,230 shares at 3.38 per share. CKPT shares that CEO, President and Director owns now total 3,194,583.

Among the insiders who sold shares, GRAY WILLIAM GARRETT disposed of 268,432 shares on Dec 18 ’24 at a per-share price of $4.01. This resulted in the Chief Financial Officer holding 1,032,754 shares of CKPT after the transaction. In another insider transaction, Oliviero James F III sold 24,610 shares at $2.05 per share on Jun 26 ’24. Company shares held by the CEO, President and Director now total 1,977,170.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, CKPT has a high of $4.50 and a low of $1.38.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. CKPT’s latest balance sheet shows that the firm has $54.73M in Cash & Short Term Investments as of fiscal 2021. Its Book Value Per Share was -$0.27, while its Total Shareholder’s Equity was $29.75M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CKPT is Buy with a score of 5.00.

Most Popular

Related Posts